2,3,5,6-tetrachloro-4-(methylsulfonyl)pyridine: has antibacterial activity; structure in first source
ID Source | ID |
---|---|
PubMed CID | 61579 |
SCHEMBL ID | 68355 |
MeSH ID | M0465725 |
Synonym |
---|
pyridine, 4-(methylsulfonyl)-2,3,5,6-tetrachloro- |
sa 1013 |
epa pesticide chemical code 068901 |
caswell no. 830a |
2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine |
pyridine, 2,3,5,6-tetrachloro-4-(methylsulfonyl)- |
tetrachloromethylsulfonylpyridine |
dowicil s-13 |
brn 1537517 |
2,3,5,6-tetrachloro-4-(methylsulfonyl)pyridine |
4-(methylsulfonyl)-2,3,5,6-tetrachloropyridine |
einecs 236-035-5 |
2,3,5,6-tetrachloro-4-methylsulfonylpyridine |
2,3,5,6-tetrachloro-4-(methylsulfonyl) pyridine |
2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine;tetrachloro-4-(methylsulfonyl)pyridine;2,3,5,6-tetrachloro-4-(methylsulfonyl)pyridine |
A26183 |
2,3,5,6-tetrochloro-4-(methylsulfonyl)pyridine |
13108-52-6 |
unii-92agr11yjb |
92agr11yjb , |
5-21-02-00127 (beilstein handbook reference) |
AKOS015913924 |
tetrachloro-4-(methylsulfonyl)pyridine, 2,3,5,6- |
SCHEMBL68355 |
T3670 |
DTXSID4044795 |
methyl 2,3,5,6-tetrachloro-4-pyridyl sulfone |
W-108340 |
c6h3cl4no2s |
mfcd00054553 |
FT-0717242 |
Q5230387 |
DS-15470 |
CS-0150153 |
2,3,5,6-tetrachloro-4-methanesulfonylpyridine |
Excerpt | Reference | Relevance |
---|---|---|
" As the respiratory chain is similar in all living organisms, it can be concluded that the toxic effect of TCMS most likely depend on the different bioavailability of the compound and on the different importance of mitochondria in the ATP production in the animal species." | ( TCMS inhibits ATP synthesis in mitochondria: a systematic analysis of the inhibitory mechanism. Ballarin, L; Bragadin, M; Cima, F; Iero, A; Manente, S, 2007) | 0.34 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.28) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 4 (57.14%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 3 (42.86%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |